The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine

L Baron, A Gombault, M Fanny, B Villeret… - Cell death & …, 2015 - nature.com
The NLR pyrin domain containing 3 (NLRP3) inflammasome is a major component of the
innate immune system, but its mechanism of activation by a wide range of molecules …

Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives

E Ozaki, M Campbell, SL Doyle - Journal of inflammation research, 2015 - Taylor & Francis
The inflammasome is a molecular platform formed by activation of an innate immune pattern
recognition receptor seed, such as NLRP3. Once activated, NLRP3 recruits the adapter ASC …

[HTML][HTML] Age-induced NLRP3 inflammasome over-activation increases lethality of SARS-CoV-2 pneumonia in elderly patients

PC Lara, D Macías-Verde, J Burgos-Burgos - Aging and disease, 2020 - ncbi.nlm.nih.gov
Age is one of the most important prognostic factors associated to lethality in SARS-CoV-2
infection. In multivariate analysis, advanced age was an independent risk factor for death …

SARS-COV-2 viroporins activate the NLRP3-inflammasome by the mitochondrial permeability transition pore

JW Guarnieri, A Angelin, DG Murdock… - Frontiers in …, 2023 - frontiersin.org
Background Compared to healthy controls, severe COVID19 patients display increased
levels of activated NLRP3-inflammasome (NLRP3-I) and interleukin (IL)-1β. SARS-CoV-2 …

The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases

HM Blevins, Y Xu, S Biby, S Zhang - Frontiers in aging neuroscience, 2022 - frontiersin.org
The NLRP3 inflammasome is a multiprotein complex that plays a pivotal role in regulating
the innate immune system and inflammatory signaling. Upon activation by PAMPs and …

Pharmacological inhibitors of the NLRP3 inflammasome

A Zahid, B Li, AJK Kombe, T Jin, J Tao - Frontiers in immunology, 2019 - frontiersin.org
Inflammasomes play a crucial role in innate immunity by serving as signaling platforms
which deal with a plethora of pathogenic products and cellular products associated with …

Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023

M Duan, L Sun, X He, Z Wang, Y Hou, Y Zhao - European Journal of …, 2023 - Elsevier
Nod-like receptor protein 3 (NLRP3), a therapeutic target that has a close relationship with
inflammatory diseases, has drawn significant attention from researchers in the field. An …

The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases

H Jiang, T Gong, R Zhou - Advances in immunology, 2020 - Elsevier
The NLRP3 inflammasome is a cytoplasmic multiprotein complex, the assembly of which
can be initiated in response to various exogenous or endogenous danger signals …

Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases

X Zhang, A Xu, J Lv, Q Zhang, Y Ran, C Wei… - European journal of …, 2020 - Elsevier
NLRP3 (Nod-like receptor protein 3) belongs to the NOD-like receptor family, which is
activated by pathogen and damage-associated signals to form a multimeric protein complex …

The signaling pathways regulating NLRP3 inflammasome activation

M Chen, X Ye, X He, D Ouyang - Inflammation, 2021 - Springer
The NLRP3 inflammasome is a multi-molecular complex that acts as a molecular platform to
mediate caspase-1 activation, leading to IL-1β/IL-18 maturation and release in cells …